Market Entry for Healthtech Companies: Europe and North America

Entering new markets is a complex challenge for healthtech ventures, requiring a deep understanding of different countries and market segments. To ensure a successful market entry, startups must analyse key factors such as: Biggest unmet needs, market size and growth potential, Reimbursement pathways, Regulatory requirements, and Competitive landscape. Market potential can vary significantly depending on these factors. We help startups navigate this complexity by conducting in-depth market analyses and developing expert-validated go-to-market strategies. This approach ensures a strong product-market fit—one of the key drivers of successful market entry. Our project is structured into two phases: 1. Kickoff Workshop: We identify the most critical aspects to validate and develop a venture-specific validation plan. 2. Market Validation: Using internal expertise, expert interviews, and desk research, we validate the key success factors for market entry. We have successfully conducted over 300 projects in market validation and business development across key markets such as Germany, the UK, France, Switzerland, the US, and many more. The final deliverable is a comprehensive report outlining the most relevant insights, along with clear recommendations and next steps. This project can also be combined with a business development initiative, where we provide hands-on support to acquire strategic partners and (pilot) customers in your target markets.